Microbubble mediated sonoporation of cells in suspension: clonogenic viability and influence of molecular size on uptake.
This work investigates whether the application of sonoporation is limited by the size of a macromolecule being delivered and by the ability of cells to proliferate following uptake. KHT-C cells in suspension were exposed to variations in ultrasound pressure (0-570 kPa) and microbubble shell-type (lipid and protein) at fixed settings of 500 kHz centre frequency, 32 micros pulse duration, 3 kHz pulse repetition frequency and 2 min insonation. Reversible permeability (P(R)), defined as the number of cells stained with FITC-dextran and unstained with propidium iodide (i.e., PI-viable), was measured with flow cytometry for marker molecules ranging from 10 kDa to 2 MDa in size. Viable permeability (P(V)) defined as the number of permeabilised cells that maintained their ability to proliferate, was measured by clonogenic assay. Comparable intracellular delivery of all sizes of molecules was achieved, indicating that intracellular delivery of common therapeutic drugs may not be limited by molecular size. Maximum P(R)'s of 80% (at 10 kDa) and 55% (at 10 kDa) were achieved with lipid coated bubbles at 3.3% v/v and protein coated bubbles at 6.7% v/v concentrations. The PI-viability was approximately 80% at 570 kPa in both cases. The maximum P(V) achieved with both agents was 22%, while inducing a lower overall clonogenic viability with the lipid (39%) compared to the protein (56%) shelled bubbles. This study demonstrates that large macromolecules, up to 2 MDa in size, can be delivered with high efficiency to cells which undergo reversible permeabilisation, maintaining long-term viability in approximately half of the cells.
Medical Biophysics, University of Toronto, Toronto, ON, Canada. karshafian@ryerson.ca
Raffi
R
Karshafian
Sanya
S
Samac
Peter D
PD
Bevan
Peter N
PN
Burns
D000418:Albumins / Q000493:pharmacokinetics; D000818:Animals; D002463:Cell Membrane Permeability; D003114:Colony-Forming Units Assay; D003287:Contrast Media / Q000493:pharmacokinetics; D003911:Dextrans; D016503:Drug Delivery Systems / Q000379:methods*; D005434:Flow Cytometry; D016650:Fluorescein-5-isothiocyanate / Q000031:analogs & derivatives; D005466:Fluorocarbons / Q000493:pharmacokinetics; D046911:Macromolecular Substances; D051379:Mice; D045423:Microbubbles; D008970:Molecular Weight; D010316:Particle Size; D011419:Propidium; D013010:Sonication / Q000379:methods*; D013535:Suspensions; D014407:Tumor Cells, Cultured
D000418:Albumins; D003287:Contrast Media; D003911:Dextrans; C099458:FS 069; D005466:Fluorocarbons; D046911:Macromolecular Substances; D013535:Suspensions; C015219:fluorescein isothiocyanate dextran; D011419:Propidium; D016650:Fluorescein-5-isothiocyanate; C042852:perflutren